![](https://investor.ananda.co.th/storage/company-info/board/wiboon.png)
Mr. Wiboon Rasmeepaisarn
Independent Director
- Member of the Nomination and Remuneration Committee
Age
- 61 years
Appointment Date
- 12 May 2011
Family Relationship between Directors and Executives
- - None -
Education
- Master of Business Administration Thammasat University
- Bachelor of Accounting Chulalongkorn University
Training Courses
Training Courses by Thai Institute of Directors:
- Director Accreditation Program Class 28/2004
- Director Certification Program Class 147/2011
- Role of the Compensation Committee Class 13/2011
- Monitoring Fraud Risk Management Class 8/2012
- Monitoring of the Quality of Financial Reporting Class 16/2012
- Monitoring the Internal Audit Function Class 13/2012
- Monitoring system of Internal Control and Risk Management Class 13/2012
- Audit Committee Program Class 41/2012
- Anti-Corruption for Executive Program Class 13/2014
- Role of the Chairman Program Class 35/2014
- Corporate Secretary Program (CSP) Class 132/2022
Working Experience in the 5 Preceding Years
Listed Company
2015 - Present
- Member of the Audit Committee / Member of the Risk Management Committee / Member of the Nomination and Remuneration Committee
Ananda Development PCL. / Real estate development and management services for real estate projects
2018 – Present
- Chairman of the Audit Committee
Mena Transport PCL. / Transportation Business
2003 - Present
- Member of the Risk Management Committee
NFC Public Company Limited / Chemical product warehouse wharf and distribution of fertilizers
Non - Listed Company
2009 – Present
- Director
Eltek Power Co., Ltd. / Importer, distributor, and installation of new electronic devices and technology and equipment on telecommunications.
1992 – Present
- Director and Managing Director
Warach Paisarn Co., Ltd. / Auditing services
2021 – Present
- Executive Director
Professional Laboratory Management Corp Plc. / Medical Laboratory
2021 – Present
- Executive Director
Sanus Technology Co., Ltd. / Manufacture and sale of drugs, pharmaceuticals, pharmaceuticals, and chemicals for medical use
Shareholding as of 31 December 2022
- - None -